TrialBritish journal of cancer2012

Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).

K Komiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.